ACIU
Income statement / Annual
Last year (2025), AC Immune SA's total revenue was $3.57 M,
a decrease of 86.92% from the previous year.
In 2025, AC Immune SA's net income was -$70.45 M.
See AC Immune SA,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.57 M |
$27.31 M |
$14.80 M |
$3.94 M |
$0.00 |
$15.43 M |
$110.46 M |
$7.19 M |
$20.26 M |
$23.21 M |
| Cost of Revenue |
$0.00
|
$62.57 M
|
$54.61 M
|
$0.00
|
$0.00
|
$59.49 M
|
$50.43 M
|
$44.28 M
|
$32.66 M
|
$25.77 M
|
| Gross Profit |
$3.57 M
|
-$35.26 M
|
-$39.81 M
|
$3.94 M
|
$0.00
|
-$44.06 M
|
$60.02 M
|
-$37.08 M
|
-$12.41 M
|
-$2.56 M
|
| Gross Profit Ratio |
1
|
-1.29
|
-2.69
|
1
|
0
|
-2.86
|
0.54
|
-5.15
|
-0.61
|
-0.11
|
| Research and Development Expenses |
$56.44 M
|
$62.57 M
|
$54.61 M
|
$60.34 M
|
$62.28 M
|
$59.49 M
|
$50.43 M
|
$44.28 M
|
$32.66 M
|
$25.77 M
|
| General & Administrative Expenses |
$11.65 M
|
$11.43 M
|
$10.58 M
|
$9.58 M
|
$10.88 M
|
$18.56 M
|
$16.06 M
|
$7.56 M
|
$6.27 M
|
$4.73 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.65 M
|
$11.43 M
|
$10.58 M
|
$9.58 M
|
$10.88 M
|
$18.56 M
|
$16.06 M
|
$7.56 M
|
$6.27 M
|
$4.73 M
|
| Other Expenses |
$4.35 M
|
-$56.89 M
|
-$51.36 M
|
$4.86 M
|
$5.85 M
|
-$60.84 M
|
-$51.00 M
|
$4.90 M
|
$3.86 M
|
$3.17 M
|
| Operating Expenses |
$72.44 M
|
$17.12 M
|
$13.82 M
|
$74.78 M
|
$79.01 M
|
$17.20 M
|
$15.49 M
|
$56.74 M
|
$42.79 M
|
$33.67 M
|
| Cost And Expenses |
$72.44 M
|
$79.69 M
|
$68.43 M
|
$74.78 M
|
$79.01 M
|
$76.69 M
|
$65.92 M
|
$56.74 M
|
$42.79 M
|
$33.67 M
|
| Interest Income |
$1.87 M
|
$3.20 M
|
$1.04 M
|
$69.00 K
|
$6.49 M
|
$78.00 K
|
$303.00 K
|
$127.00 K
|
$330.00 K
|
$43.00 K
|
| Interest Expense |
$191.00 K
|
$133.00 K
|
$176.00 K
|
$355.00 K
|
$581.00 K
|
$184.00 K
|
$1.93 M
|
$334.00 K
|
$147.00 K
|
$256.00 K
|
| Depreciation & Amortization |
$2.50 M
|
$2.16 M
|
$2.22 M
|
$2.36 M
|
$2.41 M
|
$1.54 M
|
$1.27 M
|
$961.00 K
|
$580.00 K
|
$278.00 K
|
| EBITDA |
-$67.75 M |
-$48.62 M |
-$51.83 M |
-$68.03 M |
-$70.01 M |
-$59.73 M |
$45.81 M |
-$49.66 M |
-$22.54 M |
-$6.81 M |
| EBITDA Ratio |
-18.96
|
-1.78
|
-3.5
|
-17.29
|
0
|
-3.87
|
0.41
|
-6.9
|
-1.11
|
-0.29
|
| Operating Income Ratio |
-19.27
|
-1.92
|
-3.62
|
-18
|
0
|
-3.97
|
0.4
|
-6.89
|
-1.11
|
-0.45
|
| Total Other Income/Expenses Net |
-$1.58 M
|
$1.47 M
|
-$599.00 K
|
$107.00 K
|
$6.02 M
|
-$661.00 K
|
$906.00 K
|
-$1.40 M
|
-$3.87 M
|
$3.36 M
|
| Income Before Tax |
-$70.45 M
|
-$50.91 M
|
-$54.22 M
|
-$70.74 M
|
-$72.99 M
|
-$61.92 M
|
$45.44 M
|
-$50.95 M
|
-$26.41 M
|
-$7.10 M
|
| Income Before Tax Ratio |
-19.72
|
-1.86
|
-3.66
|
-17.98
|
0
|
-4.01
|
0.41
|
-7.08
|
-1.3
|
-0.31
|
| Income Tax Expense |
$0.00
|
$3.00 K
|
$10.00 K
|
$13.00 K
|
$3.00 K
|
$0.00
|
$0.00
|
$0.00
|
$147.00 K
|
$0.00
|
| Net Income |
-$70.45 M
|
-$50.92 M
|
-$54.23 M
|
-$70.75 M
|
-$73.00 M
|
-$61.92 M
|
$45.44 M
|
-$50.95 M
|
-$26.41 M
|
-$7.10 M
|
| Net Income Ratio |
-19.72
|
-1.86
|
-3.66
|
-17.98
|
0
|
-4.01
|
0.41
|
-7.08
|
-1.3
|
-0.31
|
| EPS |
-0.7 |
-0.51 |
-0.64 |
-0.85 |
-0.97 |
-0.86 |
0.64 |
-0.82 |
-0.46 |
-0.14 |
| EPS Diluted |
-0.7 |
-0.51 |
-0.64 |
-0.85 |
-0.97 |
-0.86 |
0.64 |
-0.82 |
-0.46 |
-0.14 |
| Weighted Average Shares Out |
$100.75 M
|
$99.69 M
|
$84.69 M
|
$83.55 M
|
$74.95 M
|
$71.90 M
|
$70.60 M
|
$61.84 M
|
$57.08 M
|
$50.10 M
|
| Weighted Average Shares Out Diluted |
$100.75 M
|
$99.69 M
|
$84.69 M
|
$83.55 M
|
$74.95 M
|
$71.90 M
|
$71.10 M
|
$61.84 M
|
$57.36 M
|
$50.10 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
